Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo

被引:35
作者
Katunuma, N [1 ]
Matsui, A
Inubushi, T
Murata, E
Kakegawa, H
Ohba, Y
Turk, D
Turk, V
Tada, Y
Asao, T
机构
[1] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan
[2] Inst Taiho Pharmaceut Co, Hanno, Japan
[3] Jozef Stefan Inst, Dept Biochem, Ljubljana, Slovenia
[4] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
关键词
vitamin B-6; cathepsin K; cathepsin S; pyridoxal derivatives; pyridoxal phosphate;
D O I
10.1006/bbrc.1999.1953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found that pyridoxal phosphate shows considerable inhibition of cathepsins. CLIK-071, in which the phosphate ester of position 3 of pyridoxal phosphate was replaced by propionate, strongly inhibited cathepsin B. Three new types of synthetic pyridoxal propionate derivatives showing specific inhibition of cathepsin K were developed. New synthetic pyridoxal propionate derivatives, -162, -163, and -164, in which the methyl arm of position 6 of CLIK-071 was additionally modified, strongly inhibited cathepsin K and cathepsin S weakly, but other cathepsins were not inhibited. CLIK-166, in which the position 4 aldehyde of CLIK-071 is replaced by a vinyl radical and position 5 is additionally modified, showed cathepsin K-specific inhibition at 10(-5) M. Pit formation due to bone collagen degradation by cathepsin K of rat osteoclasts was specifically suppressed by administration of CLIK-164, but not by inhibitors of cathepsin L or B. (C) 2000 Academic Press.
引用
收藏
页码:850 / 854
页数:5
相关论文
共 22 条
[11]  
MCDONALD JK, 1969, J BIOL CHEM, V244, P6199
[12]   Crystal structure of human cathepsin K complexed with a potent inhibitor [J].
McGrath, ME ;
Klaus, JL ;
Barnes, MG ;
Bromme, D .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (02) :105-109
[13]   1,25-DIHYDROXYVITAMIN-D3 STIMULATES RAT OSTEOBLASTIC CELLS TO RELEASE A SOLUBLE FACTOR THAT INCREASES OSTEOCLASTIC BONE-RESORPTION [J].
MCSHEEHY, PMJ ;
CHAMBERS, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) :425-429
[14]   THE REFINED 2.15-A X-RAY CRYSTAL-STRUCTURE OF HUMAN LIVER CATHEPSIN-B - THE STRUCTURAL BASIS FOR ITS SPECIFICITY [J].
MUSIL, D ;
ZUCIC, D ;
TURK, D ;
ENGH, RA ;
MAYR, I ;
HUBER, R ;
POPOVIC, T ;
TURK, V ;
TOWATARI, T ;
KATUNUMA, N ;
BODE, W .
EMBO JOURNAL, 1991, 10 (09) :2321-2330
[15]   PURIFICATION AND CHARACTERIZATION OF CATHEPSIN-J FROM RAT-LIVER [J].
NIKAWA, T ;
TOWATARI, T ;
KATUNUMA, N .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (01) :381-393
[16]  
Robson LC, 1980, VITAMIN B6 METABOLIS, P205
[17]   AMINO-ACID SEQUENCE OF RAT-LIVER CATHEPSIN-L [J].
TOWATARI, T ;
KATUNUMA, N .
FEBS LETTERS, 1988, 236 (01) :57-61
[18]   NOVEL EPOXYSUCCINYL PEPTIDES - A SELECTIVE INHIBITOR OF CATHEPSIN-B, INVIVO [J].
TOWATARI, T ;
NIKAWA, T ;
MURATA, M ;
YOKOO, C ;
TAMAI, M ;
HANADA, K ;
KATUNUMA, N .
FEBS LETTERS, 1991, 280 (02) :311-315
[19]   CRYSTAL-STRUCTURE OF CATHEPSIN-B INHIBITED WITH CA030 AT 2.0-ANGSTROM RESOLUTION - A BASIS FOR THE DESIGN OF SPECIFIC EPOXYSUCCINYL INHIBITORS [J].
TURK, D ;
PODOBNIK, M ;
POPOVIC, T ;
KATUNUMA, N ;
BODE, W ;
HUBER, R ;
TURK, V .
BIOCHEMISTRY, 1995, 34 (14) :4791-4797
[20]   CHYMOSTATIN, A NEW CHYMOTRYPSIN INHIBITOR PRODUCED BY ACTINOMYCETES [J].
UMEZAWA, H ;
AOYAGI, T ;
MORISHIM.H ;
KUNIMOTO, S ;
MATSUZAK.M ;
HAMADA, M ;
TAKEUCHI, T .
JOURNAL OF ANTIBIOTICS, 1970, 23 (08) :425-&